Opendata, web and dolomites

iPLACENTA SIGNED

Innovation in modelling Placenta for Maternal and Fetal Health

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 iPLACENTA project word cloud

Explore the words cloud of the iPLACENTA project. It provides you a very rough idea of what is the project "iPLACENTA" about.

tools    innovation    springboard    located    iplacenta    business    etn    laser    academics    coordinates    openinnovation    modalities    disciplinary    beneficiaries    fetal    placenta    vivo    mathematical    prognosis    sectorial    universities    brings    academic    visualsonics    clinic    visualisation    organ    investigation    arguably    act    clinical    intersectoral    human    clinicians    openscience    models    global    samsung    wp1    chip    validate    international    participating    silico    law    esrs    complicated    fifteen    developer    pregnancies    moor    network    companies    sam    wp2    eleven    health    mim    specialist    fujiffilm    leaders    businesses    delivered    least    career    brands    wp3    diagnosis    combination    cardiovascular    fuj    world    doctoral    animal    schools    link    countries    mimetas    stage    ultrasound    industry    expertise    maternal    whilst    nih    vitro    training    ten    inter    visualise    industrial    model    cross   

Project "iPLACENTA" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF DUNDEE 

Organization address
address: Nethergate
city: DUNDEE
postcode: DD1 4HN
website: www.dundee.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 3˙929˙698 €
 EC max contribution 3˙929˙698 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF DUNDEE UK (DUNDEE) coordinator 546˙575.00
2    ST GEORGE'S HOSPITAL MEDICAL SCHOOL UK (LONDON) participant 546˙575.00
3    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 525˙751.00
4    MIMETAS BV NL (Leiden) participant 510˙748.00
5    ASTON UNIVERSITY UK (BIRMINGHAM) participant 273˙287.00
6    UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK IE (Cork) participant 265˙674.00
7    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 258˙061.00
8    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 255˙374.00
9    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 250˙560.00
10    UNIVERSITAET ROSTOCK DE (ROSTOCK) participant 249˙216.00
11    FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA ES (VALENCIA) participant 247˙872.00
12    Action on Pre-Eclampsia UK (Evesham) partner 0.00
13    EUROPEAN FOUNDATION FOR THE CARE OF NEWBORN INFANTS DE (MUNCHEN) partner 0.00
14    Facilitate Open Science Training for European Research PT (Braga) partner 0.00
15    FUJIFILM VisualSonics NL (Amsterdam) partner 0.00
16    ISTANBUL UNIVERSITESI TR (ISTANBUL) partner 0.00
17    Samsung Healthcare KR (Seúl) partner 0.00
18    University of Helsinki FI (Helsinki) partner 0.00

Map

 Project objective

“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together four different businesses; two established companies as beneficiaries Mimetas (MIM) (organ-on-a-chip developer) and Moor, a clinical-technology specialist, together with two partners that are industrial global brands Samsung (SAM) and FujifFilm VisualSonics (FUJ). Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.

 Publications

year authors and title journal last update
List of publications.
2020 Karen Melchiorre, Basky Thilaganathan, Veronica Giorgione, Anna Ridder, Alessia Memmo, Asma Khalil
Hypertensive Disorders of Pregnancy and Future Cardiovascular Health
published pages: , ISSN: 2297-055X, DOI: 10.3389/fcvm.2020.00059
Frontiers in Cardiovascular Medicine 7 2020-04-24
2020 Soragni C, Rabussier G, Lanz HL, de Windt LJ, Trietsch SJ, Ng CP
Barrier integrity of HUVEC cultured in 3-lane Organoplate® with low level of oxygen
published pages: , ISSN: , DOI:
International Cell Culture Under Flow Meeting 2020, Abstract Book 2020 2020-03-05
2019 ​Loscalzo G, Moralles-Roselló J, García Gimenez JL, Martinez Priego L, González-Rodríguez D, Mena Mollá S, Maquieira Catalá A, Buongiorno S, Cañada Martínez AJ, Perales Marín A
​MicroRNA-148B-3P and MicroRNA-25-3P are overexpressed in fetuses with late-onset fetal growth restriction
published pages: Abstract 28, ISSN: , DOI:
8th International Conference on Fetal Growth 2019 2019-11-28
2019 Lermant, Murdoch
Cysteine Glutathionylation Acts as a Redox Switch in Endothelial Cells
published pages: 315, ISSN: 2076-3921, DOI: 10.3390/antiox8080315
Antioxidants 8/8 2019-08-29
2019 Anna Ridder, Veronica Giorgione, Asma Khalil, Basky Thilaganathan
Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
published pages: 3263, ISSN: 1422-0067, DOI: 10.3390/ijms20133263
International Journal of Molecular Sciences 20/13 2019-09-02
2019 Clara Apicella, Camino S. M. Ruano, Céline Méhats, Francisco Miralles, Daniel Vaiman
The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia
published pages: 2837, ISSN: 1422-0067, DOI: 10.3390/ijms20112837
International Journal of Molecular Sciences 20/11 2019-09-02
2019 Samprikta Manna, Cathal McCarthy, Fergus P. McCarthy
Placental Ageing in Adverse Pregnancy Outcomes: Telomere Shortening, Cell Senescence, and Mitochondrial Dysfunction
published pages: 1-11, ISSN: 1942-0900, DOI: 10.1155/2019/3095383
Oxidative Medicine and Cellular Longevity 2019 2019-07-08
2019 Basky Thilaganathan, Erkan Kalafat
Cardiovascular System in Preeclampsia and Beyond
published pages: 522-531, ISSN: 0194-911X, DOI: 10.1161/hypertensionaha.118.11191
Hypertension 73/3 2019-08-05
2018 Dongqing Guo, Colin E. Murdoch, Tianhua Liu, Jia Qu, Shihong Jiao, Yong Wang, Wei Wang, Xing Chen
Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.00428
Frontiers in Pharmacology 9 2019-07-08

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IPLACENTA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IPLACENTA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

GREAT (2019)

Grating Reflectors Enabled laser Applications and Training

Read More  

LIVE-I (2020)

Lightening and Innovating transmission for improving Vehicle: Environmental Impacts

Read More  

LongActNow (2019)

Long Acting Medicines for Complex Therapeutics Needed Now

Read More